Consequently, despite our negative result on the causal effect of adiponectin, leptin, and resistin on RA risk, the role of these adipokines in inflammation and immunomodulation is well documented and, thereby, not challenged by this study. The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.